We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease

News   May 15, 2013

 
AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
 
 
 

RELATED ARTICLES

Even Short-term Vaping Causes Inflammation in Non-smokers, Says Pilot Study

News

Researchers report the first evidence of biological changes correlated with e-cigarette use in never-smokers.

READ MORE

Drug–Light Combo Could Help Control CAR T-cell Therapy

News

Researchers are one step closer to making CAR T-cell therapy safer, more exact and easy to control.

READ MORE

Bypassing the Blood-Brain-Barrier: Delivering Drugs to the Brain

News

Researchers have found a way to effectively transport medication into the brain - which could improve treatments for neurological and neurodegenerative diseases.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE